论文部分内容阅读
目的:研究探讨利凡诺联合米非司酮与米索前列醇对于终止妊娠的临床效果,并对其并发症的发生率进行探讨,为临床终止妊娠提供理论参考依据。方法:对我站自2011年11月至2012年11月收治的50例自愿终止妊娠妇女的临床资料进行回顾性分析。将其平均分为两组,研究组和对照组,每组25例。研究组25例自愿终止妊娠妇女对其采用利凡诺联合米非司酮与米索前列醇终止其妊娠;对照组25例自愿终止妊娠妇女直接对其采用利凡诺而不使用其他任何终止妊娠的药物。对比两组自愿终止妊娠妇女的临床疗效、阴道出血量、妊娠物排除的时间以及两组患者的手术后不良反应。评价利凡诺联合米非司酮与米索前列醇对于终止妊娠的临床效果。结果:两组患者对比,研究组妇女终止妊娠总有效率为96.0%,而对照组妇女终止妊娠总有效率为76.0%,研究组总有效率显著高于对照组,结果具有统计学意义(P<0.05)。研究组患者的阴道出血量、妊娠物排除的时间以及手术后并发症均优于对照组,结果具有统计学意义(P<0.05)。结论:利凡诺联合米非司酮与米索前列醇终止妊娠的临床效果优异,能够显著缩短患者产程,并且能够显著减少胎盘胎膜残留,并发症发生率低,阴道出血量少,妊娠物排除时间也较短,减少了患者的痛苦,值得广大医务工作者在临床上广泛使用。
Objective: To study the clinical efficacy of Rivaroxetine in combination with mifepristone and misoprostol in terminating pregnancy, and to explore the incidence of complications and provide a theoretical basis for clinical termination of pregnancy. Methods: Retrospective analysis was performed on the clinical data of 50 women who voluntarily terminate pregnancy who were treated in our station from November 2011 to November 2012. The average was divided into two groups, study group and control group, 25 cases in each group. In the study group, 25 women who voluntarily terminate the pregnancy terminated their pregnancy with rivanol combined with mifepristone and misoprostol. In the control group, 25 women who voluntarily terminate the pregnancy took rivanol directly without any other termination of pregnancy Drug. The clinical efficacy, vaginal bleeding volume, time of exclusion of pregnancy and postoperative adverse reactions in two groups were compared between two groups of women who voluntarily terminated pregnancy. To evaluate the clinical efficacy of rivanol combined with mifepristone and misoprostol for termination of pregnancy. Results: Compared with the control group, the total effective rate of termination of pregnancy was 96.0% in study group and 76.0% in control group. The total effective rate in study group was significantly higher than that in control group (P <0.05). The vaginal bleeding volume, time of exclusion of pregnancy and postoperative complications in the study group were better than those in the control group, with statistical significance (P <0.05). Conclusion: Rivanol combined with mifepristone and misoprostol has the clinical effect of termination of pregnancy, can significantly shorten the patient’s labor, and can significantly reduce the residual placental membranes, complications, low incidence of vaginal bleeding, pregnancy Excluding time is also shorter, reducing the suffering of patients, it is worth the majority of medical workers in clinical widely used.